← back to search

Joshua R. Korzenik

Harvard University · US
Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Gut microbiota and health, and Immunodeficiency and Autoimmune Disorders.
h-index
56
citations
17,651
works
322
NIH funding
primary concept
Medicine
email

Recent publications

Cultured bacteria isolated from primary sclerosing cholangitis patient bile induce inflammation and cell death.
2025cited by 0position: contributordoi
Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas
Cell 2024cited by 83position: middledoi
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis
Hepatology Communications 2024cited by 7position: middledoi
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis.
2024cited by 4position: contributordoi
Identification of environmental factors that promote intestinal inflammation.
2022cited by 116position: contributordoi
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial
Alimentary Pharmacology & Therapeutics 2022cited by 17position: middledoi
Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Comorbid Irritable Bowel Syndrome and Inflammatory Bowel Disease
Clinical and Translational Gastroenterology 2022cited by 16position: lastdoi
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Inflammatory Bowel Diseases 2021cited by 54position: middledoi
Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn’s Disease
Gastroenterology 2020cited by 342position: middledoi
South Asian Patients With Inflammatory Bowel Disease in the United States Demonstrate More Fistulizing and Perianal Crohn Phenotype
Inflammatory Bowel Diseases 2020cited by 34position: middledoi
Challenges in IBD Research: Environmental Triggers
Inflammatory Bowel Diseases 2019cited by 93position: middledoi
Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis
Crohn s & Colitis 360 2019cited by 20position: middledoi
Association of urinary phenolic compounds, inflammatory bowel disease and chronic diarrheal symptoms: Evidence from the National Health and Nutrition Examination Survey
Environmental Pollution 2017cited by 35position: middledoi
Recurrent <i>Clostridium difficile</i> infection associates with distinct bile acid and microbiome profiles
Alimentary Pharmacology & Therapeutics 2016cited by 193position: lastdoi
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
Science Translational Medicine 2015cited by 438position: middledoi
Vitamin D Supplementation Modulates T Cell–Mediated Immunity in Humans: Results from a Randomized Control Trial
The Journal of Clinical Endocrinology & Metabolism 2015cited by 66position: middledoi
A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative Colitis
Gastroenterology 2013cited by 629position: middledoi
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease
Proceedings of the National Academy of Sciences 2013cited by 113position: middledoi
Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 6 Boston Academic Hospitals
Inflammatory Bowel Diseases 2013cited by 22position: middledoi
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Genome biology 2012cited by 2,754position: middledoi
Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease
PLoS ONE 2012cited by 290position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2022–2025)Punyanganie S. de Silva · Brigham and Women's Hospital3 papers (2013–2020)Ashwin N. Ananthakrishnan · Harvard University2 papers (2013–2019)Dirk Gevers · Johnson & Johnson (United States)2 papers (2012–2012)Eric J. Alm · Amgen (United States)2 papers (2012–2016)Bruce E. Sands · Seattle University2 papers (2012–2022)Francis A. Farraye · Mayo Clinic in Florida2 papers (2013–2019)Christopher L. Bowlus · Washington State University2 papers (2024–2024)Scott B. Snapper · Université Mohammed VI Polytechnique2 papers (2012–2019)Ramnik J. Xavier · Broad Institute2 papers (2012–2012) · 2 papers (2013–2019)Doyle V. Ward · University of Massachusetts Chan Medical School2 papers (2012–2012)Andrew T. Chan · Monash Institute of Medical Research2 papers (2013–2015) · 2 papers (2013–2015)Sushrut Jangi · Brigham and Women's Hospital1 papers (2020–2020)Laurie H. Glimcher · Boston Medical Center1 papers (2015–2015)Stephen M. Rappaport · University of California, Berkeley1 papers (2019–2019)Vikas Pabby · University of California, Los Angeles1 papers (2013–2013)Joseph Ahn · Mayo Clinic1 papers (2024–2024)Melanie Grant · Advanced Cell Technology (United States)1 papers (2019–2019)